ArticleRheumatology international2014

Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement.

Agata Kosmaczewska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.